AVITA Medical Inc (NASDAQ:RCEL)
| 12.80 Delayed Data As of Mar 24 |  -0.07 / -0.54%Today’s Change | 4.41 Today|||52-Week Range 14.75 | +93.94% Year-to-Date |
Latest RCEL News | Press Releases
| 89bio (ETNB) Up 25% on Upbeat Data From Mid-Stage NASH Study Mar 23 / Zacks.com - Paid Partner Content | Merck's (MRK) Co-formulation Therapy Fails Lung Cancer Study Mar 17 / Zacks.com - Paid Partner Content |
| BridgeBio Pharma (BBIO) Surges 77% YTD: Here's Why Mar 22 / Zacks.com - Paid Partner Content | Catalyst's (CPRX) Q4 Earnings & Sales Top, Boosted by Firdapse Mar 16 / Zacks.com - Paid Partner Content |
| Altimmune (ALT) Stock Down Despite Positive Obesity Study Data Mar 22 / Zacks.com - Paid Partner Content | What Makes Avita Medical Inc. (RCEL) a Good Fit for 'Trend Investing' Mar 16 / Zacks.com - Paid Partner Content |
| Karuna's (KRTX) KarXT Meets Primary Goal in Schizophrenia Study Mar 21 / Zacks.com - Paid Partner Content | How Much Upside is Left in Avita Medical Inc. (RCEL)? Wall Street Analysts Think 27.42% Mar 14 / Zacks.com - Paid Partner Content |
| Esperion (ESPR) Plummets 54% Over Milestone Payment Row Mar 17 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 12.87 |
| Today’s open | 12.60 |
| Day’s range | 12.56 - 12.85 |
| Volume | 1,946 |
| Average volume (3 months) | 119,337 |
| Market cap | $323.8M |
Data as of 3:59pm ET, 03/24/2023
Growth & Valuation
| Earnings growth (last year) | +9.02% |
| Earnings growth (this year) | -3.61% |
| Earnings growth (next 5 years) | -3.12% |
| Revenue growth (last year) | +17.75% |
| P/E ratio | NM |
| Price/Sales | 3.40 |
| Price/Book | 3.81 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| VYGRVoyager Therapeutics... | -0.11 | -1.47% |
| AUTLAutolus Therapeutics... | -0.05 | -2.67% |
| BNGOBionano Genomics Inc | +0.01 | +0.92% |
| STOKStoke Therapeutics I... | -0.22 | -2.80% |
Data as of 4:00pm ET, 03/24/2023
Financials
| Next reporting date | May 11, 2023 |
| EPS forecast (this quarter) | -$0.27 |
| Annual revenue (last year) | $34.4M |
| Annual profit (last year) | -$26.7M |
| Net profit margin | -77.47% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Valencia, California |
Forecasts
